Stay updated on Vilazodone Safety in GAD: Clinical Trial
Sign up to get notified when there's something new on the Vilazodone Safety in GAD: Clinical Trial page.
Latest updates to the Vilazodone Safety in GAD: Clinical Trial page
- Check7 days agoChange DetectedRevision: v3.3.2 replaces the previous v3.3.1 on the page.SummaryDifference0.0%
- Check14 days agoChange DetectedPublication section wording updated to 'automatically filled in from PubMed' (instead of 'come from PubMed'), and the revision label changed from v3.2.0 to v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%
- Check21 days agoChange DetectedRemoved the site-wide government funding lapse notice and NIH/Clinical Center operating status references from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%
- Check36 days agoChange DetectedNo additions or deletions were observed on the study page; core study information remains the same. If any minor visual adjustments exist, they do not affect the main content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%
- Check64 days agoChange DetectedMajor update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.SummaryDifference4%
- Check72 days agoChange DetectedCore page content is largely unchanged; however, several MedlinePlus topics were removed and the page version updated to v3.1.0, indicating a cleanup of topics rather than addition of new content.SummaryDifference0.7%
Stay in the know with updates to Vilazodone Safety in GAD: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Vilazodone Safety in GAD: Clinical Trial page.